• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在杜氏肌营养不良症中,舒更葡糖钠逆转罗库溴铵诱导的深度神经肌肉阻滞。

Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.

作者信息

de Boer Hans D, van Esmond Jan, Booij Leo H J D, Driessen Jacques J

机构信息

Department of Anesthesiology and Pain Medicine, Martini General Hospital Groningen, Groningen, The Netherlands.

出版信息

Paediatr Anaesth. 2009 Dec;19(12):1226-8. doi: 10.1111/j.1460-9592.2009.03178.x. Epub 2009 Oct 23.

DOI:10.1111/j.1460-9592.2009.03178.x
PMID:19863737
Abstract

A case is reported in which a child with Duchenne muscular dystrophy received a dose of sugammadex to reverse a rocuronium-induced profound neuromuscular block. Sugammadex is the first selective relaxant binding agent and reverses rocuronium- and vecuronium-induced neuromuscular block. A fast and efficient recovery from profound neuromuscular block was achieved, and no adverse events or other safety concerns were observed.

摘要

报道了一例患有杜氏肌营养不良症的儿童接受一剂舒更葡糖以逆转罗库溴铵诱导的深度神经肌肉阻滞的病例。舒更葡糖是首个选择性肌松药结合剂,可逆转罗库溴铵和维库溴铵诱导的神经肌肉阻滞。该患儿实现了从深度神经肌肉阻滞中快速有效恢复,且未观察到不良事件或其他安全问题。

相似文献

1
Reversal of rocuronium-induced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy.在杜氏肌营养不良症中,舒更葡糖钠逆转罗库溴铵诱导的深度神经肌肉阻滞。
Paediatr Anaesth. 2009 Dec;19(12):1226-8. doi: 10.1111/j.1460-9592.2009.03178.x. Epub 2009 Oct 23.
2
Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.舒更葡糖钠逆转罗库溴铵(1.2毫克/千克)所致深度神经肌肉阻滞:一项多中心、剂量探索及安全性研究。
Anesthesiology. 2007 Aug;107(2):239-44. doi: 10.1097/01.anes.0000270722.95764.37.
3
Neuromuscular transmission: new concepts and agents.神经肌肉传递:新概念与药物
J Crit Care. 2009 Mar;24(1):36-42. doi: 10.1016/j.jcrc.2008.08.004. Epub 2009 Jan 17.
4
Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.罗库溴铵诱导的神经肌肉阻滞与舒更葡糖钠用于杜氏肌营养不良症患儿:一例报告
Medicine (Baltimore). 2017 Mar;96(13):e6456. doi: 10.1097/MD.0000000000006456.
5
Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.Cochrane 专栏: sugammadex,一种用于预防术后残余神经肌肉阻滞的选择性逆转药物。
Anesth Analg. 2010 Apr 1;110(4):1239. doi: 10.1213/ANE.0b013e3181ce8d5e.
6
Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.舒更葡糖钠用于小儿和成人外科手术患者中逆转罗库溴铵诱导的神经肌肉阻滞作用
Anesthesiology. 2009 Feb;110(2):284-94. doi: 10.1097/ALN.0b013e318194caaa.
7
Reversal of rocuronium-induced (1.2 mg kg-1) profound neuromuscular block by accidental high dose of sugammadex (40 mg kg-1).意外大剂量舒更葡糖钠(40mg/kg)逆转罗库溴铵(1.2mg/kg)所致深度神经肌肉阻滞。
Br J Anaesth. 2007 May;98(5):624-7. doi: 10.1093/bja/aem057. Epub 2007 Mar 8.
8
Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial.在两个不同时间点使用舒更葡糖钠逆转深度、高剂量罗库溴铵诱导的神经肌肉阻滞:一项国际、多中心、随机、剂量探索、安全性评估者设盲的II期试验
Anesthesiology. 2008 Aug;109(2):188-97. doi: 10.1097/ALN.0b013e31817f5bc7.
9
Reversal of neuromuscular block with a selective relaxant-binding agent: sugammadex.使用选择性肌松药结合剂逆转神经肌肉阻滞:舒更葡糖钠。
Am J Ther. 2009 Jul-Aug;16(4):295-9. doi: 10.1097/MJT.0b013e31817fe2d7.
10
Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.在一项随机多中心研究中,舒更葡糖钠对罗库溴铵所致深度神经肌肉阻滞的早期逆转作用:疗效、安全性及药代动力学
Anesthesiology. 2007 May;106(5):935-43. doi: 10.1097/01.anes.0000265152.78943.74.

引用本文的文献

1
Pharmacological interventions for the management of anesthesia and sedation in patients with Duchenne muscular dystrophy: a systematic review and meta-analysis.杜氏肌营养不良症患者麻醉和镇静管理的药理学干预:系统评价和荟萃分析
Front Med (Lausanne). 2025 Jan 27;12:1497538. doi: 10.3389/fmed.2025.1497538. eCollection 2025.
2
Advanced Heart Failure Therapies in Neuromuscular Diseases.神经肌肉疾病中的晚期心力衰竭治疗
Curr Treat Options Cardiovasc Med. 2024 Aug;26(8):255-270. doi: 10.1007/s11936-024-01046-2. Epub 2024 Jun 25.
3
Sugammadex for our little ones: a brief narrative review.
用于我们的小朋友们的舒更葡糖钠:一篇简要叙述性综述。
Anesth Pain Med (Seoul). 2024 Oct;19(4):269-279. doi: 10.17085/apm.24092. Epub 2024 Oct 31.
4
Eliminating residual neuromuscular blockade: a literature review.消除残余肌松作用:文献综述
Ann Transl Med. 2024 Aug 1;12(4):65. doi: 10.21037/atm-23-1743. Epub 2024 May 14.
5
Neuromuscular Blocking Agents and Reversal Agents Among Hospitalized Children: A Cerner Database Study.住院儿童中的神经肌肉阻滞剂和逆转剂:一项Cerner数据库研究
Hosp Pharm. 2021 Oct;56(5):424-429. doi: 10.1177/0018578720918332. Epub 2020 May 5.
6
Adult North Star Network (ANSN): Consensus Guideline For The Standard Of Care Of Adults With Duchenne Muscular Dystrophy.成人北星网络(ANSN):杜氏肌营养不良症成人护理标准共识指南。
J Neuromuscul Dis. 2021;8(6):899-926. doi: 10.3233/JND-200609.
7
Sugammadex: Applications in Pediatric Critical Care.舒更葡糖钠:在儿科重症监护中的应用
J Pediatr Intensive Care. 2020 Sep;9(3):162-171. doi: 10.1055/s-0040-1705133. Epub 2020 Mar 6.
8
Anesthesia in a patient with Charcot-Marie-Tooth disease with pneumothorax: a case report.患有夏科-马里-图思病且并发气胸患者的麻醉:一例报告
J Int Med Res. 2019 Nov;47(11):5896-5902. doi: 10.1177/0300060519881239. Epub 2019 Oct 20.
9
Multidisciplinary Perioperative Care for Children with Neuromuscular Disorders.神经肌肉疾病患儿的多学科围手术期护理
Children (Basel). 2018 Sep 12;5(9):126. doi: 10.3390/children5090126.
10
Sugammadex: Appropriate Use in the Context of Budgetary Constraints.舒更葡糖钠:在预算限制背景下的合理使用。
Curr Anesthesiol Rep. 2018;8(2):178-185. doi: 10.1007/s40140-018-0265-6. Epub 2018 Mar 20.